1
Mohamed SKIBA Mohamed SKIBA
Skiba Mohamed, Skiba Malika, Duclos Roselyne, Combret Jean Claude, Arnaud Philippe: Cyclodextrins substituted by fluoroalkyl groups, preparation and use thereof. Univ Rouen, August 21, 2002: EP1232188-A1

The invention concerns alpha, beta or gamma cyclodextrin derivatives, monosubstituted to persubstituted on the primary and/or secondary hydroxyl groups by one or several identical or different fluoroalkyl groups. The invention also concerns nanoparticles consisting of said cyclodextrin derivatives, ...


2
Mohamed SKIBA Mohamed SKIBA
Skiba Mohamed, Skiba Malika, Duclos Roselyne, Combret Jean Claude, Arnaud Philippe: Cyclodextrines monosubstitues a persubstitues par des groupements fluoroalkyles, leur preparation et leur utilisation. Univ Rouen, February 2, 2001: FR2796955-A1

The invention concerns alpha, beta or gamma cyclodextrin derivatives, monosubstituted to persubstituted on the primary and/or secondary hydroxyl groups by one or several identical or different fluoroalkyl groups. The invention also concerns nanoparticles consisting of said cyclodextrin derivatives, ...


3
Malini Batheja, Ph.D
Quay Steven C, Gupta Malini, de, Meireles Jorge C, Abd, El Shafy Mohammed: Compositions and method for enhanced mucosal delivery of interferon beta. Nastech Pharmaceutical Company, LUNN Paul G, January 8, 2004: WO/2004/002404 (8 worldwide citation)

Compositions and methods are provided for intranasal delivery of interferon-&bgr; yielding improved pharmacokinetic and pharmacodynamic results. In certain aspects of the invention, the interferon-&bgr; is delivered to the intranasal mucosa along with one or more intranasal delivery-enhancing agent( ...


4
Malini Batheja, Ph.D
Quay Steven C, de, Meireles Jorge C, Gupta Malini, Vangala Shyam: Compositions and methods for enhanced mucosal delivery of growth hormone. Nastech Pharmaceutical Company, Quay Steven C, de, Meireles Jorge C, Gupta Malini, Vangala Shyam, LUNN Paul G, January 20, 2005: WO/2005/004895 (2 worldwide citation)

Pharmaceutical formulations are described comprising at least one growth hormone and one or more intranasal delivery-enhancing agents for enhanced nasal mucosal delivery of the growth hormone. In one aspect, the intranasal delivery formulations and methods provide enhanced delivery of growth hormone ...


5
Malini Batheja, Ph.D
Quay Steven C, de Meireles Jorge C, Gupta Malini, Vangala Shyam: Compositions and methods for enhanced mucosal delivery of growth hormone. Nastech Pharm Co, April 12, 2006: EP1643970-A2

Pharmaceutical formulations are described comprising at least one growth hormone and one or more intranasal delivery-enhancing agents for enhanced nasal mucosal delivery of the growth hormone. In one aspect, the intranasal delivery formulations and methods provide enhanced delivery of growth hormone ...


6
Malini Batheja, Ph.D
Quay Steven C, Gupta Malini, de Meireles Jorge C, Abd El Shafy Mohammed: Compositions and methods for enhanced mucosal delivery of interferon beta. Nastech Pharm Co, June 15, 2005: EP1539220-A2

Compositions and methods are provided for intranasal delivery of interferon-beta yielding improved pharmacokinetic and pharmacodynamic results. In certain aspects of the invention, the interferon-beta is delivered to the intranasal mucosa along with one or more intranasal delivery-enhancing agent(s) ...


7
Theeuwes Felix, Higuchi Takeru: Osmatic dispensing device for releasing beneficial agent. Alza Corporation, Sabatine Paul L, Mandell Edward L, Benz William H, November 5, 1974: US3845770 (1481 worldwide citation)

A wall surrounding and forming a compartment for containing a useful composition of matter and having a passageway for dispensing the composition is disclosed. The wall is comprised in at least a part of a material permeable to an external fluid. The composition is soluble in the fluid and exhibits ...


8
Theeuwes Felix, Higuchi Takeru: Osmotic dispensing device with maximum and minimum sizes for the passageway. Alza Corporation, Sabatine Paul L, Mandell Edward L, Ciotti Thomas E, November 4, 1975: US3916899 (1286 worldwide citation)

A device is disclosed comprised of a wall surrounding and forming a compartment for containing a useful composition of matter and having a passageway for dispensing the compostion. The wall is comprised in at least a part of a material permeable to an external fluid. The composition is soluble in th ...


9

10
Zaffaroni Alejandro: Bandage for the administration of drug by controlled metering through microporous materials. Alza Corporation, March 19, 1974: US3797494 (330 worldwide citation)

A bandage for use in the continuous administration of drugs to the skin or mucosa, comprising a backing member defining one exterior surface, a surface of pressure-sensitive adhesive defining a second exterior surface, and disposed therebetween a reservoir containing drug formulation confined therei ...